Detalhe da pesquisa
1.
The dual action of human antibodies specific to Plasmodium falciparum PfRH5 and PfCyRPA: Blocking invasion and inactivating extracellular merozoites.
PLoS Pathog
; 19(9): e1011182, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37713419
2.
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex.
Nat Commun
; 15(1): 4857, 2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38849365
3.
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens.
Front Immunol
; 14: 1193079, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299155
4.
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection.
Sci Transl Med
; 15(704): eadf1782, 2023 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37437014
5.
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate.
Nat Commun
; 13(1): 933, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35177602
6.
Impact of a blood-stage vaccine on Plasmodium vivax malaria.
medRxiv
; 2022 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664997